Interplay of Multipathway Dyslipidemia, Inflammation, and Cholesterol-Lowering Medication in Modifying Abdominal Aortic Aneurysm Risk

Arteriosclerosis, Thrombosis, and Vascular Biology · Published 2026-05-21 · DOI 10.1161/atvbaha.126.324423

Authors (12)

Yiting Wu, Dan Chen, Yanjun Zhang, Ziliang Ye, Sisi Yang, Xiaoqin Gan, Yu Huang, Yiwei Zhang, Xianglian Cai, Xiaolong Liang, Yuanyuan Zhang, Xianhui Qin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wu, Y., Chen, D., Zhang, Y., et al. (2026). Interplay of Multipathway Dyslipidemia, Inflammation, and Cholesterol-Lowering Medication in Modifying Abdominal Aortic Aneurysm Risk. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.324423

Related articles